Report Detail
Global Bone Morphogenetic Protein (BMP) 2 Market Insights, Forecast to 2025
- RnM3048872 |
- 01 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022.
Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016.
North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Bone Morphogenetic Protein (BMP) 2 market is valued at 390 million US$ in 2018 and will reach 450 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bone Morphogenetic Protein (BMP) 2 market based on company, product type, end user and key regions.
This report studies the global market size of Bone Morphogenetic Protein (BMP) 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bone Morphogenetic Protein (BMP) 2 in these regions.
This research report categorizes the global Bone Morphogenetic Protein (BMP) 2 market by top players/brands, region, type and end user. This report also studies the global Bone Morphogenetic Protein (BMP) 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Cellumed
Market size by Product
Sponge
Gel
Market size by End User
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Bone Morphogenetic Protein (BMP) 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bone Morphogenetic Protein (BMP) 2 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bone Morphogenetic Protein (BMP) 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bone Morphogenetic Protein (BMP) 2 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bone Morphogenetic Protein (BMP) 2 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bone Morphogenetic Protein (BMP) 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Bone Morphogenetic Protein (BMP) 2 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Product
- 1.4.2 Sponge
- 1.4.3 Gel
- 1.5 Market by End User
- 1.5.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by End User
- 1.5.2 Spinal Fusion
- 1.5.3 Trauma Surgery
- 1.5.4 Oral Maxillofacial Surgery
- 1.5.5 Reconstructive
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size
- 2.1.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue 2014-2025
- 2.1.2 Global Bone Morphogenetic Protein (BMP) 2 Sales 2014-2025
- 2.2 Bone Morphogenetic Protein (BMP) 2 Growth Rate by Regions
- 2.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales by Regions
- 2.2.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Bone Morphogenetic Protein (BMP) 2 Sales by Manufacturers
- 3.1.1 Bone Morphogenetic Protein (BMP) 2 Sales by Manufacturers
- 3.1.2 Bone Morphogenetic Protein (BMP) 2 Sales Market Share by Manufacturers
- 3.1.3 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR5 and HHI)
- 3.2 Bone Morphogenetic Protein (BMP) 2 Revenue by Manufacturers
- 3.2.1 Bone Morphogenetic Protein (BMP) 2 Revenue by Manufacturers (2014-2019)
- 3.2.2 Bone Morphogenetic Protein (BMP) 2 Revenue Share by Manufacturers (2014-2019)
- 3.3 Bone Morphogenetic Protein (BMP) 2 Price by Manufacturers
- 3.4 Bone Morphogenetic Protein (BMP) 2 Manufacturing Base Distribution, Product Types
- 3.4.1 Bone Morphogenetic Protein (BMP) 2 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Bone Morphogenetic Protein (BMP) 2 Product Type
- 3.4.3 Date of International Manufacturers Enter into Bone Morphogenetic Protein (BMP) 2 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Bone Morphogenetic Protein (BMP) 2 Sales by Product
- 4.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Product
- 4.3 Bone Morphogenetic Protein (BMP) 2 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Bone Morphogenetic Protein (BMP) 2 Breakdown Data by End User
6 North America
- 6.1 North America Bone Morphogenetic Protein (BMP) 2 by Countries
- 6.1.1 North America Bone Morphogenetic Protein (BMP) 2 Sales by Countries
- 6.1.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Bone Morphogenetic Protein (BMP) 2 by Product
- 6.3 North America Bone Morphogenetic Protein (BMP) 2 by End User
7 Europe
- 7.1 Europe Bone Morphogenetic Protein (BMP) 2 by Countries
- 7.1.1 Europe Bone Morphogenetic Protein (BMP) 2 Sales by Countries
- 7.1.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Bone Morphogenetic Protein (BMP) 2 by Product
- 7.3 Europe Bone Morphogenetic Protein (BMP) 2 by End User
8 Asia Pacific
- 8.1 Asia Pacific Bone Morphogenetic Protein (BMP) 2 by Countries
- 8.1.1 Asia Pacific Bone Morphogenetic Protein (BMP) 2 Sales by Countries
- 8.1.2 Asia Pacific Bone Morphogenetic Protein (BMP) 2 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Bone Morphogenetic Protein (BMP) 2 by Product
- 8.3 Asia Pacific Bone Morphogenetic Protein (BMP) 2 by End User
9 Central & South America
- 9.1 Central & South America Bone Morphogenetic Protein (BMP) 2 by Countries
- 9.1.1 Central & South America Bone Morphogenetic Protein (BMP) 2 Sales by Countries
- 9.1.2 Central & South America Bone Morphogenetic Protein (BMP) 2 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Bone Morphogenetic Protein (BMP) 2 by Product
- 9.3 Central & South America Bone Morphogenetic Protein (BMP) 2 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 by Countries
- 10.1.1 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Sales by Countries
- 10.1.2 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 by Product
- 10.3 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 by End User
11 Company Profiles
- 11.1 Medtronic
- 11.1.1 Medtronic Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Products Offered
- 11.1.5 Medtronic Recent Development
- 11.2 Cellumed
- 11.2.1 Cellumed Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Products Offered
- 11.2.5 Cellumed Recent Development
12 Future Forecast
- 12.1 Bone Morphogenetic Protein (BMP) 2 Market Forecast by Regions
- 12.1.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Forecast by Regions 2019-2025
- 12.2 Bone Morphogenetic Protein (BMP) 2 Market Forecast by Product
- 12.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Forecast by Product 2019-2025
- 12.2.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Forecast by Product 2019-2025
- 12.3 Bone Morphogenetic Protein (BMP) 2 Market Forecast by End User
- 12.4 North America Bone Morphogenetic Protein (BMP) 2 Forecast
- 12.5 Europe Bone Morphogenetic Protein (BMP) 2 Forecast
- 12.6 Asia Pacific Bone Morphogenetic Protein (BMP) 2 Forecast
- 12.7 Central & South America Bone Morphogenetic Protein (BMP) 2 Forecast
- 12.8 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Bone Morphogenetic Protein (BMP) 2 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Bone Morphogenetic Protein (BMP) 2 . Industry analysis & Market Report on Bone Morphogenetic Protein (BMP) 2 is a syndicated market report, published as Global Bone Morphogenetic Protein (BMP) 2 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Bone Morphogenetic Protein (BMP) 2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
